FMCKO Stock | News | Quote | Stock Forum | Saturday, October

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
Freddie Mac FMCKO Company Overview 

Stock Message Board http://investorshangout.com/search?q=FMCKO&am...mp;yt1=Go!

Last Updated: Saturday, October 26, 2013 02:54:59 AM

Freddie Mac FMCKO Current Price and Quotes
Last Price 5.28
Previous Close 5.36 Open 5.36
Daily Range 5.36 - 5.26 52wk Range 6.80 - 1.35
Volume 567,000 Dividend N/A
Average Vol (3m) 40,237 Yield N/A
Freddie Mac FMCKO
Company Information

8200 Jones Branch Drive
McLean, VA 22102

Website: http://www.freddiemac.com
Phone: 703-903-2000

Freddie Mac FMCKO
Freddie Mac was chartered by Congress in 1970 with a public mission to stabilize the nation’s residential mortgage markets and expand opportunities for home ownership and affordable rental housing.

Freddie Mac FMCKO
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Jun 30, 2013 10-Q
CIK 0001026214
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 6111 - Federal and federally sponsored credit
Incorporated In: USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts

Donald H. Layton CEO
Ross J. Kari CFO
John R. Dye Senior VP, Corporate Secretary
Company Directors

Not Available
Company Notes

Formerly=Federal Home Loan Mortgage Corp. until 7-97
Service Providers

Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

Freddie Mac FMCKO
FMCKO Security Details Other Company Securities

Share Structure

Market Value1 $105,600,000 a/o Oct 25, 2013
Shares Outstanding 20,000,000 a/o Oct 16, 2006
Float Not Available
Authorized Shares Not Available
Par Value  No Par Value
Shareholders

Shareholders of Record Not Available
Short Selling Data

Short Interest 488 (169.61%)
Sep 30, 2013
Significant Failures to Deliver  No
Transfer Agent(s)



Freddie Mac FMCKO Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 80,635,000 88,262,000 98,368,000 37,614,000
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses

Research and Development - - - -
Sales, General and Admin. 2,193,000 2,483,000 2,932,000 7,195,000
Non-Recurring Items - - - -
Other 1,890,000 10,702,000 17,218,000 29,530,000
Operating Income - - - -
Income From Continuing Operations

Add'l Income/Expense Items - - - -
Earnings Before Interest and Tax 76,552,000 75,077,000 78,218,000 889,000
Interest Expense 67,107,000 80,743,000 93,100,000 23,273,000
Earnings Before Tax 9,445,000 (5,666,000) (14,882,000) (22,384,000)
Income Tax (1,537,000) (400,000) (856,000) (830,000)
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 10,982,000 (5,266,000) (14,026,000) (21,554,000)
Non Recurring Events

Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 10,982,000 (5,266,000) (14,026,000) (21,554,000)
Preferred Stock and Other Adjustments (13,056,000) (6,498,000) (5,749,000) (4,105,000)
Net Income Applicable to Common Shareholders (2,074,000) (11,764,000) (19,774,000) (25,658,000)

Freddie Mac FMCKO Recent News

FMCKO Freddie Mac Research DD Guide

Stock Message Board http://investorshangout.com/search?q=FMCKO&am...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/FMCKO/quote
Stock Chart http://www.otcmarkets.com/stock/FMCKO/chart
Company Info http://www.otcmarkets.com/stock/FMCKO/company-info
Recent News http://www.otcmarkets.com/stock/FMCKO/news
Financials http://www.otcmarkets.com/stock/FMCKO/financials
Filings and Disclosure http://www.otcmarkets.com/stock/FMCKO/filings
Short Sales http://www.otcmarkets.com/stock/FMCKO/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/FMCKO/insider-transactions
Research Reports http://www.otcmarkets.com/stock/FMCKO/research
Summary http://finance.yahoo.com/q?s=FMCKO
Historical Prices http://finance.yahoo.com/q/hp?s=FMCKO+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=FMCKO
Basic Chart http://finance.yahoo.com/q/bc?s=FMCKO+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=FMCKO+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=FMCKO+Headlines
Press Releases http://finance.yahoo.com/q/p?s=FMCKO+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=FMCKO+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=FMCKO+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=FMCKO+Industry
Major Holders http://finance.yahoo.com/q/mh?s=FMCKO+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=FMCKO+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=FMCKO+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=FMCKO
Balance Sheet http://finance.yahoo.com/q/bs?s=FMCKO
Cash Flow http://finance.yahoo.com/q/cf?s=FMCKO+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/FMCKO
Market Watch http://www.marketwatch.com/investing/stock/FMCKO
Bloomberg http://www.bloomberg.com/quote/FMCKO:US
Morningstar http://quotes.morningstar.com/stock/s?t=FMCKO
Bussinessweek http://investing.businessweek.com/research/st...cker=FMCKO
Barchart http://www.barchart.com/quotes/stocks/FMCKO
OTC Short Report http://otcshortreport.com/index.php?index=FMCKO
Investopedia http://www.investopedia.com/markets/stocks/FMCKO/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading